Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Food-effect crossover study of NOMAC-E2 tablet formulations
NL-OMON35968Active, not recruiting
- Sponsor
- Merck & Co.
- Start
- May 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised trial of nomegestrol acetate + estradiol in contraception (3 arms), sponsored by Merck & Co. Primary endpoints: Pharmacokinetics of nomegestrol acetate after commercial formulation under fed versus fasted conditions, Pharmacokinetics of estradiol after commercial formulation under fed versus fasted conditions and 1 more. Started May 2011; status: active, not recruiting.
02
Drugs
nomegestrol acetate + estradiol
03
Conditions
contraception
Beyond the preview
Go deeper on NL-OMON35968.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON35968.